425

Compound name
Nimotuzumab
Compound Image
Nimotuzumab.png
Approval Jurisdiction
2014 China, India
Approved for clinical use
Cell Carcinomas Of The Head And Neck
CAS
780758-10-3
Action
EGFR
Approved Drug List
1
Commercial Vendor
Biotech Pharm.